Dr. Mitra Margaret Campbell, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 6001 Kyle Pkwy, Kyle, TX 78640 Phone: 512-504-5125 |
Jesse Steven Rodriguez, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 135 Bunton Creek Rd, Suite 100, Kyle, TX 78640 Phone: 512-268-2068 |
Shana Godfred-cato, D.O. Emergency Medicine - Pediatric Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4100 Everett, Suite 400, Kyle, TX 78640 Phone: 512-295-1333 Fax: 512-406-7327 |
Dr. Dawn Ann Mudie, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 6001 Kyle Pkwy, Kyle, TX 78640 Phone: 512-504-5125 |
News Archive
Harvard stem cell scientists have discovered that a recently approved medication for epilepsy may possibly be a meaningful treatment for amyotrophic lateral sclerosis (ALS)-Lou Gehrig's disease, a uniformly fatal neurodegenerative disorder. The researchers are now collaborating with Massachusetts General Hospital to design an initial clinical trial testing the safety of the treatment in ALS patients.
In an interview with Reuters, Health and Human Services Secretary Kathleen Sebelius "said she is pushing [insurance] companies to help people gain insurance in the gap between now and 2014. That is when the healthcare law President Barack Obama signed in March mandates extensive changes. Sebelius struck a cooperative tone after publicly chastising insurers for high rate hikes ... and after repeatedly calling them to the White House for highly publicized talks. A more congenial relationship with insurers could help keep the major overhaul of the healthcare system on track and loosen strained relations between Democrats and big business ahead of the November midterm elections" (Richwine, 7/8).
Many survivors of breast cancer cite stress as a link to the cancer despite no scientific proof of a connection. Experts believe that the root cause here are the lifestyle-related issues - such as smoking and obesity - where there is a clear link to the cancer.
A large-scale clinical trial to evaluate whether a candidate vaccine can prevent the mosquito-borne illness dengue fever has been launched in Brazil. The vaccine, TV003, was developed by scientists in the laboratory of Stephen Whitehead, Ph.D., at NIH's National Institute of Allergy and Infectious Diseases (NIAID).
› Verified 6 days ago